OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 122 filers reported holding OCULAR THERAPEUTIX INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $546,884 | -47.2% | 174,167 | -13.3% | 0.01% | -58.3% |
| Q2 2023 | $1,036,350 | +287775.0% | 200,843 | +193.7% | 0.01% | +100.0% |
| Q1 2023 | $360 | +29.0% | 68,384 | -31.2% | 0.01% | 0.0% |
| Q4 2022 | $279 | -99.9% | 99,338 | +60.8% | 0.01% | 0.0% |
| Q3 2022 | $256,000 | +24.9% | 61,775 | +21.0% | 0.01% | +20.0% |
| Q2 2022 | $205,000 | -28.3% | 51,039 | +24.5% | 0.01% | 0.0% |
| Q4 2021 | $286,000 | -69.8% | 40,987 | -56.7% | 0.01% | -66.7% |
| Q3 2021 | $947,000 | +695.8% | 94,712 | +645.8% | 0.02% | +400.0% |
| Q4 2015 | $119,000 | -67.9% | 12,700 | -28.1% | 0.00% | -72.7% |
| Q2 2015 | $371,000 | – | 17,663 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,932,607 | $40,643,000 | 15.56% |
| Lamond Capital Partners LLC | 711,533 | $14,964,000 | 15.19% |
| Polaris Venture Management Co. V, L.L.C. | 1,230,009 | $25,867,000 | 11.54% |
| NOTTINGHAM ADVISORS, INC. | 171,985 | $3,617,000 | 0.60% |
| Portolan Capital Management | 122,518 | $2,577,000 | 0.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 160,000 | $3,365,000 | 0.33% |
| Rotella Capital Management, Inc. | 18,461 | $388,000 | 0.32% |
| Monashee Investment Management LLC | 28,834 | $606,000 | 0.29% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 335,498 | $7,056,000 | 0.24% |
| BAILARD, INC. | 55,000 | $1,157,000 | 0.18% |